Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
4.830
+0.140 (2.99%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Curis Revenue

Curis had revenue of $7.06M in the twelve months ending March 31, 2026, down -36.95% year-over-year. In the year 2025, Curis had annual revenue of $9.44M, down -13.43%.

Revenue (ttm)
$7.06M
Revenue Growth
-36.95%
P/S Ratio
1.33
Revenue / Employee
$294,292
Employees
24
Market Cap
9.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.44M-1.47M-13.43%
Dec 31, 202410.91M885.00K8.83%
Dec 31, 202310.02M-139.00K-1.37%
Dec 31, 202210.16M-487.00K-4.57%
Dec 31, 202110.65M-186.00K-1.72%
Dec 31, 202010.84M831.00K8.31%
Dec 31, 201910.00M-424.00K-4.07%
Dec 31, 201810.43M530.00K5.35%
Dec 31, 20179.90M2.37M31.50%
Dec 31, 20167.53M-351.00K-4.46%
Dec 31, 20157.88M-1.97M-19.96%
Dec 31, 20149.84M-5.16M-34.39%
Dec 31, 201315.00M-1.97M-11.61%
Dec 31, 201216.97M2.21M14.97%
Dec 31, 201114.76M-1.24M-7.73%
Dec 31, 201016.00M7.41M86.26%
Dec 31, 20098.59M223.32K2.67%
Dec 31, 20088.37M-8.02M-48.95%
Dec 31, 200716.39M1.45M9.73%
Dec 31, 200614.94M8.93M148.83%
Dec 31, 20056.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Immuron4.99M
Vistagen Therapeutics1.27M
Exicure500.00K
Aspire Biopharma Holdings34.56K
BioCardia3.00K
Revenue Rankings